Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Tax Provisions (2023 - 2025)

Eton Pharmaceuticals' Tax Provisions history spans 3 years, with the latest figure at -$28000.0 for Q3 2025.

  • For Q3 2025, Tax Provisions rose 77.78% year-over-year to -$28000.0; the TTM value through Sep 2025 reached $199000.0, up 13.71%, while the annual FY2024 figure was $15000.0, 93.93% down from the prior year.
  • Tax Provisions for Q3 2025 was -$28000.0 at Eton Pharmaceuticals, down from $66000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $247000.0 in Q4 2023 and bottomed at -$126000.0 in Q3 2024.
  • The 3-year median for Tax Provisions is $66000.0 (2025), against an average of $53428.6.
  • The largest annual shift saw Tax Provisions tumbled 64.78% in 2024 before it surged 77.78% in 2025.
  • A 3-year view of Tax Provisions shows it stood at $247000.0 in 2023, then crashed by 64.78% to $87000.0 in 2024, then crashed by 132.18% to -$28000.0 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Tax Provisions are -$28000.0 (Q3 2025), $66000.0 (Q2 2025), and $74000.0 (Q1 2025).